#DeathCross $SCP.AX at 2.54 R5 HiLo 57% T1Y 2 none PE 13.7 DIV 5.87% #SHOPCENAUS #Australia #trading #markets

2019-03-12
59 Views

Death Cross detected for SCP.AX (SHOPCENAUS STAPLED) at the close price of 2.54. Trading at a 57 % level between the 52week High (2.74) and 52week Low (2.27).
The average analyst 1-year target price is 2.0 with an average none and a score of 0.0.

Death Cross 5 % SCP.AX 2.54
SHOPCENAUS STAPLED HiLo 57.4 pc
Support 2.41 Resistance 2.54
50DMA 2.50 200DMA 2.50
52week high 2.74 52week low 2.27
10DMA 2.45 20DMA 2.45
100 Mean 2.56
Volume 5082478 AvgDayVol 3311513
MarketCap 2350980608 EBITDA 0
Revenue 234800000 PE 13.73
P2S 10.01 P2B 0.00
Dividend 0.14 Div Ex-Date 2018-12-28 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#Levermann #ASIA  #BigCap #Buy WK20 $0688.HK (4)
Asia, BigCap, Bull
24 views
Asia, BigCap, Bull
24 views

#Levermann #ASIA #BigCap #Buy WK20 $0688.HK (4)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #ASIA #BigCap #Buy WK20 $0688.HK (4)

#Levermann #EU  #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)
BigCap, Bull, Europe
21 views
BigCap, Bull, Europe
21 views

#Levermann #EU #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #EU #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)

#Levermann #EU  #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)
Bear, BigCap, Europe
24 views
Bear, BigCap, Europe
24 views

#Levermann #EU #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #EU #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.